Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01598259 · ClinicalTrials.gov registry record · Phase 2

Randomized Controlled Trial to Assess Efficacy of Melatonin for Children During Burn Rehabilitation

A Phase 2 study, sponsored by Shriners Hospitals for Children.

Terminated
Registry status
Phase 2
Development phase
10
Enrollment target

NCT01598259: Clinical Trial Phase 2 study, sponsored by Shriners Hospitals for Children.

NCT01598259 is a Phase 2 study that was terminated before completion, run by Shriners Hospitals for Children. The registered enrollment target is 10 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01598259, a Phase 2 study, was terminated before completion, sponsored by Shriners Hospitals for Children.

TERMINATED
Registry status
Phase 2
Development phase
10 participants
Enrollment target

Study Summary

The specific aims of this investigation in children during burn rehabilitation include 1.) to determine the efficacy of melatonin intervention on improving sleep-related outcomes 2.) investigate the hypothesis that sleep inadequacy is associated with cognitive deficits and 3.) develop a new methodology specific for burn patients that accurately screens for the presence of intrinsic dyssomnia.

Primary Outcome

Measure sleep parameters via polysomnography, actigraphy and urinary melatonin

Interventions

  • DRUG Melatonin
  • OTHER placebo

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2014-05
Est. Completion 2016-06
Phase Phase 2
Shriners Hospitals for Children

40 total trials

Why NCT01598259 stopped before completion

NCT01598259 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Melatonin is the first listed.

NCT01598259 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01598259 about?

NCT01598259 is a clinical study titled "Randomized Controlled Trial to Assess Efficacy of Melatonin for Children During Burn Rehabilitation". The specific aims of this investigation in children during burn rehabilitation include 1.) to determine the efficacy of melatonin intervention on improving sleep-related outcomes 2.) investigate the hypothesis that sleep inadequacy is associated with cognitive deficits and 3.) develop a new methodol...

What is the current status of trial NCT01598259?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2014-05. Estimated completion is 2016-06.

What interventions are being tested in trial NCT01598259?

The interventions under investigation include: Melatonin (DRUG), placebo (OTHER).

Who is sponsoring clinical trial NCT01598259?

This trial is sponsored by Shriners Hospitals for Children, which has 40 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01598259's enrollment target sits among peer trials

10 1968th of 2000 higher than 12 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01598259, the US trial registry maintained by the National Library of Medicine. NCT01598259 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.